Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8471428rdf:typepubmed:Citationlld:pubmed
pubmed-article:8471428lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:8471428lifeskim:mentionsumls-concept:C0025196lld:lifeskim
pubmed-article:8471428lifeskim:mentionsumls-concept:C0004565lld:lifeskim
pubmed-article:8471428lifeskim:mentionsumls-concept:C0598312lld:lifeskim
pubmed-article:8471428lifeskim:mentionsumls-concept:C0243126lld:lifeskim
pubmed-article:8471428lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8471428lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8471428pubmed:issue4lld:pubmed
pubmed-article:8471428pubmed:dateCreated1993-5-14lld:pubmed
pubmed-article:8471428pubmed:abstractTextThe cellular distribution of 4-borono-2-[18F]fluoro-L-phenylalanine ([18F]FBPA, an analog of p-boronophenylaline), a potential agent for boron neutron capture therapy (BNCT), and [6-3H]thymidine ([3H]Thd, a DNA precursor) in murine two B16 melanoma sublines and FM3A mammary carcinoma was studied in vivo using double-tracer microautoradiography. Tumour volume, tumour age, cell density in the tissues and the proportion of S phase cells in the cell cycle were the same in the three tumour models. Volume doubling time, which represents tumour growth rate, was fastest in B16F10, followed by B16F1 (P < 0.05), the slowest being in FM3A (P < 0.001). The rate of DNA synthesis in S phase cells corresponded to the volume doubling time. The greatest amount of [18F]FBPA was observed in S phase melanocytes and the lowest amount was found in non-S phase non-melanocytes. The [18F]FBPA accumulation was primarily related to the activity of DNA synthesis and, secondarily, to the degree of pigmentation in melanocytes. The therapeutic efficacy of BNCT with p-boronophenylalanine may be greater in melanoma that exhibits greater DNA synthesis activity and higher melanin content.lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:languageenglld:pubmed
pubmed-article:8471428pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:citationSubsetIMlld:pubmed
pubmed-article:8471428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8471428pubmed:statusMEDLINElld:pubmed
pubmed-article:8471428pubmed:monthAprlld:pubmed
pubmed-article:8471428pubmed:issn0007-0920lld:pubmed
pubmed-article:8471428pubmed:authorpubmed-author:YamadaSSlld:pubmed
pubmed-article:8471428pubmed:authorpubmed-author:TadaMMlld:pubmed
pubmed-article:8471428pubmed:authorpubmed-author:IshiwataKKlld:pubmed
pubmed-article:8471428pubmed:authorpubmed-author:KubotaKKlld:pubmed
pubmed-article:8471428pubmed:authorpubmed-author:IdeJJlld:pubmed
pubmed-article:8471428pubmed:authorpubmed-author:KubotaRRlld:pubmed
pubmed-article:8471428pubmed:issnTypePrintlld:pubmed
pubmed-article:8471428pubmed:volume67lld:pubmed
pubmed-article:8471428pubmed:ownerNLMlld:pubmed
pubmed-article:8471428pubmed:authorsCompleteYlld:pubmed
pubmed-article:8471428pubmed:pagination701-5lld:pubmed
pubmed-article:8471428pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:meshHeadingpubmed-meshheading:8471428-...lld:pubmed
pubmed-article:8471428pubmed:year1993lld:pubmed
pubmed-article:8471428pubmed:articleTitleCellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.lld:pubmed
pubmed-article:8471428pubmed:affiliationDepartment of Radiology and Nuclear Medicine, Tohoku University, Sendai, Japan.lld:pubmed
pubmed-article:8471428pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8471428pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed